Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-006391

Chief Scientific Officer sold 21,028 shares at an average $18.39 ($386,743)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Russell Alan J Chief Scientific Officer 2021-10-06 Sale −2,108 $18.03 $38,007 171,214 D: show line 1 in the form
Russell Alan J Chief Scientific Officer 2021-10-07 Sale −13,018 $18.56 $241,614 158,196 D: show line 2 in the form
Russell Alan J Chief Scientific Officer 2021-10-08 Sale −5,902 $18.15 $107,121 152,294 D: show line 3 in the form
Open-market sales · 21,028 sh · avg $18.39 · $386,743
Loading xslF345X03/primarydocument.xml…